articles new-year-new-goals-2024 
IDStewardship
APRIL 13, 2023
In this article an infectious diseases pharmacist with experience managing antimicrobial stewardship programs discusses antimicrobial stewardship regulatory standards Authored by: Timothy P. The most recent CARB addresses the years 2020-2025, building upon the initial one released in 2015. Within the goals are more granular objectives.
IDStewardship
OCTOBER 18, 2023
In this article the students from the University of Florida discuss why they started the ChatRx podcast and what their goals are for their new endeavor. Candidate 2024 & Lucas Zhou, Pharm.D. Candidate 2024 Article Posted October 2024 Hello Readers of IDstewardship!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Thyroid Pharmacist
DECEMBER 29, 2023
Wow… do the years just fly by! I can’t believe that it’s been over 10 years since I started the thyroidpharmacist.com blog in 2013, and now 2023 is almost over. Around this time of year, I tend to be very introspective. For me, the New Year is always a great time to shed the old me, and start fresh!
Hospital Pharmacy Europe
AUGUST 21, 2023
It follows a call for evidence in November to inform the next five-year national action plan to tackle the problem. But another theme that emerged in the responses was a lack of diagnostics to ensure infections can be treated quickly and appropriately as well as a lack of innovation in developing new antimicrobials.
IDStewardship
NOVEMBER 29, 2023
In this article the host of the Let’s Talk Micro Podcast (Luis Plaza Rios) is interviewed about his experience and learning clinical microbiology using podcasting via the Let’s Talk Micro podcast. I had the pleasure to meet Luis in person and after exchanging some emails we were able to compose this article.
pharmaphorum
JANUARY 4, 2022
In this article, Ben Hargreaves explores how advances in technology could address these challenges. By 2024, this figure is expected to hit $250 billion. This has led to a greater push into developing biologic medicine and exploring new ways to discover potential R&D candidates. Artificial intelligence cracking the code.
ISPE
JULY 6, 2023
1 Although CM technology has been around for decades, it does present some novel challenges to the pharmaceutical industry, especially when the goal is to supply therapeutics globally. This has stemmed from a lack of familiarity with the “new to pharma” technology among global regulatory bodies, or at least the perception thereof.
Expert insights. Personalized for you.
236 
Let's personalize your content